|
Real-time Estimate
Cboe Europe
08:08:59 21/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 81.80 EUR | +0.49% |
|
+4.09% | +28.59% |
| 09-17 | Sources: Orion180 reportedly to price IPO below the range - BN (R) | FW |
| 09-17 | Sources: Orion180 said to price IPO below the range - BN | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 13.16B | |||||
| 1,028B | |||||
| 651B | - | ||||
| 466B | |||||
| 346B | |||||
| 266B |
- Stock Market
- Stocks
- ORNBV Stock
- ORNAV Stock
- Charts Orion Oyj
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
